Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia

Kandice E. Roberts, Michael W. Deininger, Gerhard C. Hildebrandt, Brian K. Gackenbach, Maxwell M. Krem

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology